Foresee Pharmaceuticals Advances CPP Treatment as First Clinical Trial Recommended for Continuation Foresee Pharmaceuticals' Casppian Phase 3 study receives a positive recommendation to continue, showcasing innovative treatment for Central Precocious Puberty.

Foresee Pharmaceuticals Advances CPP Treatment as First Clinical Trial Recommended for Continuation #Taiwan #Taipei #Foresee_Pharmaceuticals #CPP_Treatment #Casppian_Study

Foresee Pharmaceuticals Achieves Another Milestone in Casppian Study towards CPP Treatment Foresee Pharmaceuticals has received a positive recommendation from the Data and Safety Monitoring Board for their Casppian study, enhancing treatment options for children suffering from central precocious puberty.

Foresee Pharmaceuticals Achieves Another Milestone in Casppian Study towards CPP Treatment #Taiwan #Taipei #Foresee_Pharmaceuticals #CAMCEVI #CPP_Treatment